Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
Contact
About us
Links
Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
Contact
About us
Links
Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
About us
Contact
Links
About us
Contact
Links
Accordion Title
Accordion Content
more items +
Michael Burry added to bets on Chinese stocks last quarter — but there’s a catch
Why gold prices skidded from record highs to a losing streak in just two weeks
Powell says Fed doesn’t need to hurry to cut interest rates
Hims & Hers’ stock tumbles on Amazon’s latest disruptive foray into healthcare
Tesla and Rivian shares were having a good week. Concerns over the future of EV tax credits ended that.
A surging U.S. dollar is hammering emerging-market stocks and metals. Watch out.
When clients show signs of dementia, what should financial advisers do?
Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug
This group of cryptocurrencies is starting to make a dent in demand for short-term Treasurys
Planning a Roth IRA conversion? Trump’s win and GOP trifecta could buy you more time to act.
Bessent or Lutnick? Support for tariffs looks key as Trump weighs Treasury pick
Here’s why the FBI seized Polymarket founder’s phone
Michael Burry added to bets on Chinese stocks last quarter — but there’s a catch
Why gold prices skidded from record highs to a losing streak in just two weeks
Powell says Fed doesn’t need to hurry to cut interest rates
Hims & Hers’ stock tumbles on Amazon’s latest disruptive foray into healthcare
Tesla and Rivian shares were having a good week. Concerns over the future of EV tax credits ended that.
A surging U.S. dollar is hammering emerging-market stocks and metals. Watch out.
When clients show signs of dementia, what should financial advisers do?
Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug
This group of cryptocurrencies is starting to make a dent in demand for short-term Treasurys
Planning a Roth IRA conversion? Trump’s win and GOP trifecta could buy you more time to act.
Bessent or Lutnick? Support for tariffs looks key as Trump weighs Treasury pick
Here’s why the FBI seized Polymarket founder’s phone
Nvidia tops list of favored S&P 500 stocks on expected sales growth through 2026
14-11-24
Other expected highfliers include KKR, AMD, Microsoft and Live Nation.
Share this on:
